A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient’s cancer treatment on commonly disrupted genes and pathways.
Exploiting the use of DNA single- and double-strand breaking forms of the I-SceI endonuclease to stimulate homologous recombination and gene targeting in budding yeast and in human cells
Dr. Brendan Hunt Receives VWR Postdoctoral Award
Joel Kostka, Joshua Weitz join prestigious leadership group.
